These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10354093)

  • 1. Proteolytic inactivation of transforming growth factor beta3 by elastase in venous leg ulcers: implications for clinical trials using topically-applied peptide growth factors.
    Schmid P; Itin P; Cox D
    Br J Dermatol; 1999 Jun; 140(6):1170-2. PubMed ID: 10354093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth factors as a possibility to accelerate the healing of leg ulcers].
    Lidén S; Beitner H
    Lakartidningen; 1991 Sep; 88(37):2971-2. PubMed ID: 1921580
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
    Nayeri F; Olsson H; Peterson C; Sundqvist T
    J Dermatol Sci; 2005 Feb; 37(2):75-85. PubMed ID: 15659325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors in wound healing: the next great innovation?
    Kunimoto BT
    Ostomy Wound Manage; 1999 Aug; 45(8):56-64; quiz 65-6. PubMed ID: 10655868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with growth factors.
    Limat A; French LE
    Curr Probl Dermatol; 1999; 27():49-56. PubMed ID: 10547726
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with crude preparations of growth factors in healing of chronic wounds in human subjects.
    Carter DM; Balin AK; Gottlieb AB; Eisinger M; Lin A; Pratt L; Sherbany A; Caldwell D
    Prog Clin Biol Res; 1988; 266():303-17. PubMed ID: 3380851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local therapy of chronic arterial leg ulcers with thrombocyte growth factor].
    Jessberger S; Debus ES; Schmidt K; Reith HB; Thiede A
    Krankenpfl J; 1997; 35(7-8):293-6. PubMed ID: 9295599
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and effect of transforming growth factor-beta(2) for treatment of venous stasis ulcers.
    Robson MC; Phillip LG; Cooper DM; Lyle WG; Robson LE; Odom L; Hill DP; Hanham AF; Ksander GA
    Wound Repair Regen; 1995; 3(2):157-67. PubMed ID: 17173644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth factors on cartilage repair.
    Coutts RD; Sah RL; Amiel D
    Instr Course Lect; 1997; 46():487-94. PubMed ID: 9143992
    [No Abstract]   [Full Text] [Related]  

  • 10. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
    Kinbara T; Shirasaki F; Kawara S; Inagaki Y; de Crombrugghe B; Takehara K
    J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of platelet derived wound healing formula in human clinical trials.
    Knighton DR; Doucette M; Fiegel VD; Ciresi K; Butler E; Austin L
    Prog Clin Biol Res; 1988; 266():319-29. PubMed ID: 3289047
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth factors in the treatment of diabetic foot ulcers.
    Bennett SP; Griffiths GD; Schor AM; Leese GP; Schor SL
    Br J Surg; 2003 Feb; 90(2):133-46. PubMed ID: 12555288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of growth factors in flexor tendon wound healing.
    Hsu C; Chang J
    J Hand Surg Am; 2004 Jul; 29(4):551-63. PubMed ID: 15249076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds.
    Vooijs DP; Walboomers XF; Parker JA; Von den Hoff JW; Jansen JA
    J Biomed Mater Res A; 2004 Sep; 70(3):402-11. PubMed ID: 15293313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer.
    Galkowska H; Olszewski WL; Wojewodzka U
    Arch Dermatol Res; 2005 Jan; 296(7):286-95. PubMed ID: 15565301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma rich in growth factors as a potential therapeutic candidate for treatment of recurrent aphthous stomatitis.
    Aminabadi NA
    Med Hypotheses; 2008; 70(3):529-31. PubMed ID: 17804174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major advance in the use of growth factors to enhance wound healing.
    Sporn MB; Roberts AB
    J Clin Invest; 1993 Dec; 92(6):2565-6. PubMed ID: 8254012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Growth factors and wound healing: review and prospect in recent ten years].
    Fu X; Cheng B; Sheng Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Nov; 18(6):508-12. PubMed ID: 15586716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials with purified platelet releasate.
    Steed D; Goslen B; Hambley R; Abell E; Hebda P; Webster M
    Prog Clin Biol Res; 1991; 365():103-13. PubMed ID: 1862125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of growth factors and growth factor receptor in non-healing and healing ischaemic ulceration.
    Murphy MO; Ghosh J; Fulford P; Khwaja N; Halka AT; Carter A; Turner NJ; Walker MG
    Eur J Vasc Endovasc Surg; 2006 May; 31(5):516-22. PubMed ID: 16427789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.